Skip to content

A study of effect of Guduchyadi Churna and Vidangadi Churna in Sthoulya (Obesity)

A Randomized Comparative study of Guduchyadi Churna and Vidangadi Churna in the management of Sthoulya (Obesity) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088373
Enrollment
60
Registered
2025-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

Vd Dnyaneshwar Ritond
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient showing classical signs & symptoms of Sthoulya. 2. Age between 18 to 60 years 3. Both genders included. 4. BMI between 25 to 35.

Exclusion criteria

Exclusion criteria: 1. Drug induced obesity 2. Obesity due to secondary causes like Thyroid, Diabetes. 3. Hormonal disorders. 4. Pregnant women and lactating women. 5. Disease associated obesity. 6. BMI more than 35. 7. Obesity observed since birth

Design outcomes

Primary

MeasureTime frame
To compare efficacy of Guduchyadi Churna and Vidangadi Churna in the management of Sthoulya. 2. To assess the efficacy of Guduchyadi Churna in the management of Sthoulya. 3. To study in details about Sthoulya according to Ayurvedic classics. 4. To study Obesity in correlation with Sthoulya.Timepoint: Follow up with assessment of patient after 15 Days for 60 Days

Secondary

MeasureTime frame
Guduchyadi Churna is significantly effective than Vidangadi churna in the management of Sthoulya (Obesity).Timepoint: Follow up with assessment of patient after 15 Days for 60 Days

Countries

India

Contacts

Public ContactVd Sanjeev Lokhande

E. A. B. V. J. J. S. Ashwin Rural Ayurved College, Sangamner, Ahmadnagar

lokhandesanjeev13@gmail.com9373788599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026